COVAX delivers additional 1.18 million COVID-19 vaccine doses to Viet Nam
Ha Noi, 2nd August 2021 – Viet Nam received today 1,188,000 doses of COVID-19 vaccines from the COVAX Facility, bringing the total donations to the country to 8,681,300 doses.
“COVID-19 vaccines are lifesaving tools, but with a limited supply, prioritizing the most vulnerable is the most optimal way to save lives” says Dr Kidong Park, WHO Representative for Viet Nam. “As we face the surge of cases, we need to accelerate and ramp up our efforts in vaccinating the health workers, the elderly and those with underlying conditions to protect them from severe illness and death.”
“It is critical that priority groups, including health and social workers and teachers, are vaccinated against COVID-19 in order to ensure that children are able to return safely to school and get the preventive health services they need”, said Lesley Miller, UNICEF Deputy Representative.
Among 8,681,300 doses of COVID-19 vaccines delivered to Viet Nam through the COVAX Facility, 5,000,100 doses are Moderna vaccine from the US Government and 3,681,200 doses are AstraZeneca. The COVAX Facility is co-led by the World Health Organization (WHO), Coalition for Epidemic Preparedness and Innovations (CEPI), GAVI, the Vaccine Alliance, and UNICEF as the key delivery partner.
To date, over 6.4 million COVID-19 vaccine doses have been administered in Viet Nam, among them 659,064 second doses. The additional vaccines will help the Ministry of Health to expand coverage and reach more people from priority groups, contributing to attaining the country’s target of vaccinating more than 70 percent of the population by the end of the first quarter of 2022.
The limited global supply of COVID-19 vaccines affects the vaccination rollout in many countries. As many people remain unvaccinated, it is essential to continue the 5K: wear mask, practice physical distancing, sanitize, and avoid closed and crowded settings.
The latest shipment of Vaxzevria® vaccines (previously called COVID-19 Vaccine AstraZeneca) was developed jointly by AstraZeneca and the University of Oxford. This batch is shipped from Laboratorio Univesal Farma, manufacturing facility in Spain. The Vaxzevria COVID-19 vaccine has received the Emergency Use Authorization from WHO and has been used successfully in Viet Nam since March 2021 under its previous name.
For several months, COVAX partners, CEPI, GAVI, WHO and delivery partner UNICEF, have been supporting the Government of Viet Nam in readiness efforts and the national rollout of COVID-19 vaccines. They have been especially active in developing a National Vaccination Plan, as Viet Nam is benefiting from the Advance Market Commitment (AMC). The AMC is an innovative financial mechanism to help secure global and equitable access for COVID-19 vaccines.
Notes to Editors
- Full COVAX News Note to Editors: https://www.who.int/initiatives/act-accelerator/covax/covax-news-note-to-editors
- List of donor pledges to the Gavi COVAX AMC: https://www.gavi.org/sites/default/files/covid/covax/COVAX-AMC-Donors-Table.pdf
- UNICEF COVAX page https://www.unicef.org/supply/covax-ensuring-global-equitable-access-covid-19-vaccines
- WHO Viet Nam Page: The Oxford/AstraZeneca COVID-19 vaccine: what you need to know (who.int)
UNICEF promotes the rights and wellbeing of every child, in everything we do. Together with our partners, we work in 190 countries and territories to translate that commitment into practical action, focusing special effort on reaching the most vulnerable and excluded children, to the benefit of all children, everywhere. For more information about COVID-19, visit https://www.unicef.org/vietnam/covid-19
For more information about UNICEF and its work for children, visit https://www.unicef.org/vietnam